Skip to main content Skip to main menu
UF Health University of Florida
Faculty Advancement and Engagement University of Florida College of Medicine – Jacksonville
Katherine A Zarroli

Katherine A Zarroli, M.D.

Assistant Professor

Department: Neurology – Jacksonville
Business Phone: (904) 383-1022
Business Email: katherine.zarroli@jax.ufl.edu

On This Page

About Katherine A Zarroli

Katherine Zarroli, M.D., is a University of Florida assistant professor of neurology and a neurologist at the UF Health Neuroscience Institute specializing in clinical neurophysiology and epilepsy.

Dr. Zarroli received her medical degree from the Jefferson Medical College of Thomas Jefferson University in Philadelphia, Pennsylvania. She completed an internal medicine internship at the University of Pennsylvania in Philadelphia, and residency training in neurology at Beth Israel Deaconess Medical Center/Harvard Medical School in Boston, Massachusetts. She completed fellowships in neurophysiology and epilepsy at the University of Virginia Medical Center in Charlottesville, Virginia. Dr. Zarroli is board-certified in neurology, clinical neurophysiology, and epilepsy.

Additional Positions:
Assistant Professor of Neurology
2019 – Current · University of Florida

Accomplishments

  1. Exemplary Teacher

    University of Florida College of Medicine

  2. Exemplary Teacher

    University of Florida College of Medicine

  3. Exemplary Teacher

    University of Florida College of Medicine

  4. Golden Apple Teaching Award – Neurology Residency

    Department of Neurology, University of Florida College of Medicine – Jacksonville

  5. Exemplary Teacher

    University of Florida College of Medicine

Teaching Profile

Courses Taught

  1. MDC7800 – Neurology Clerkship

    College of Medicine

Board Certifications

  • Clinical Neurophysiology
    American Board of Psychiatry and Neurology
  • Epilepsy
    American Board of Psychiatry and Neurology
  • Neurology
    American Board of Psychiatry and Neurology

Clinical Profile

Specifically interested in the care of women with epilepsy, including but not limited to the management of epilepsy during pregnancy, as it relates to the menstrual cycle (catamenial epilepsy), and in relation to contraceptive options.

Specialties

  • Neurology

Subspecialties

  • Clinical Neurophysiology
  • Epilepsy

Areas of Interest

  • Epilepsy

Research Profile

Goal of identifying novel treatments of catamenial epilepsy.

Open Researcher and Contributor ID (ORCID)

Areas of Interest

  • Medically refractory epilepsy – surgical evaluation, treatment, and outcomes
  • Women’s Health

Publications

Academic Articles

Grants

  1. A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 as Adjunctive Therapy in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures, with Open-label Extension Epilepsy (SHINE)

    Active

    Role:
    Principal Investigator
    Funding:
    BIOHAVEN PHARMACEUTICALS

  2. A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy

    Active

    Role:
    Principal Investigator
    Funding:
    BIOHAVEN PHARMACEUTICALS

  3. A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy

    Active

    Role:
    Principal Investigator
    Funding:
    BIOHAVEN PHARMACEUTICALS

  4. SAFETY AND THERAPEUTIC MEASURES OF TRANSCRANIAL CATHODAL DIRECT CURRENT STIMULATION (TDCS) IN PATIENTS WITH REFRACTORY FOCAL EPILEPSY

    Active

    Role:
    Principal Investigator
    Funding:
    NEUROELECTRICS USA

  5. Pilot Study of Add-On Fycompa (peramapanel) Treatment for Catamenial Epilepsy

    Role:
    Principal Investigator
    Funding:
    CATALYST PHARMACEUTICALS

  6. A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

    Role:
    Principal Investigator
    Funding:
    DRUGDEV INC via EISAI CO

Education

  1. Epilepsy Fellowship

    University of Virginia Medical Center

  2. Neurophysiology Fellowship

    University of Virginia Medical Center

  3. Neurology Residency

    Beth Israel Deaconess Medical Center

  4. Doctor of Medicine

    Thomas Jefferson University

Contact Details

Phones:
Business:
(904) 383-1022
Emails:
Business:
katherine.zarroli@jax.ufl.edu
Senior Medical Secretary:
Profile photo for Jimena Herrada
Addresses:
Business Mailing:
580 W 8TH ST
 JACKSONVILLE FL 32209
Business Street:
580 W 8TH ST
9TH FLOOR, TOWER I
 JACKSONVILLE FL 322096533